H.C. Wainwright analyst Raghuram Selvaraju reiterated a Neutral rating on Co-Diagnostics (NASDAQ: CODX).The analyst commented: 'Last week, Co-Diagnostics reported its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE